The Body's Own Opioids Make Hemorrhagic Shock Worse — Blocking Them Improves Survival
Blocking opioid peptides with naloxone or specific antibodies improved hemorrhage tolerance in rats — the body's own opioid response paradoxically worsens blood loss shock.
Quick Facts
What This Study Found
Central and peripheral naloxone increased bleeding volumes before pressure dropped. Brain antibodies against beta-endorphin, alpha-endorphin, and dynorphin A also improved hemorrhage tolerance.
Key Numbers
How They Did This
Anesthetized rats underwent controlled stepwise hemorrhage. Naloxone, peripheral naloxone methobromide, or opioid peptide antibodies were administered centrally. Bleeding volumes at each pressure step were measured.
Why This Research Matters
This reveals that the body's opioid peptides actually make hemorrhagic shock worse. Blocking them could improve survival during severe blood loss, a finding relevant to trauma and emergency medicine.
The Bigger Picture
This finding has clinical implications for trauma and emergency medicine. If opioid blockers improve hemorrhage tolerance, naloxone could potentially be used as a trauma resuscitation drug.
What This Study Doesn't Tell Us
Animal study in anesthetized rats. Anesthesia and controlled hemorrhage differ from real trauma. Antibody specificity may not be perfect. Clinical translation is not straightforward.
Questions This Raises
- ?Should naloxone be administered during traumatic hemorrhage?
- ?Which opioid peptide is most responsible for worsening shock?
Trust & Context
- Key Stat:
- Opioid blockade improved hemorrhage tolerance Both central and peripheral naloxone increased the bleeding volume tolerated before dangerous blood pressure drops
- Evidence Grade:
- Preliminary animal study in anesthetized rats. Controlled hemorrhage model is artificial but allows precise measurements.
- Study Age:
- Published in 1991. Naloxone for hemorrhagic shock has been studied clinically with mixed but promising results.
- Original Title:
- Endogenous opioid peptides and blood pressure regulation during controlled, stepwise hemorrhagic hypotension.
- Published In:
- Circulatory shock, 35(2), 102-8 (1991)
- Authors:
- van den Berg, M H, van Giersbergen, P L(5), Cox-van Put, J, de Jong, W
- Database ID:
- RPEP-00216
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Why do opioids make hemorrhage worse?
During blood loss, opioid peptides may cause excessive vasodilation (blood vessel relaxation), reduce the heart's compensatory response, and blunt the sympathetic fight-or-flight response — all of which are needed to survive hemorrhage.
Could naloxone save lives in trauma?
This animal study suggests it could help. Some clinical trials have shown benefits, but the evidence is mixed. Naloxone for hemorrhagic shock remains an active area of research.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00216APA
van den Berg, M H; van Giersbergen, P L; Cox-van Put, J; de Jong, W. (1991). Endogenous opioid peptides and blood pressure regulation during controlled, stepwise hemorrhagic hypotension.. Circulatory shock, 35(2), 102-8.
MLA
van den Berg, M H, et al. "Endogenous opioid peptides and blood pressure regulation during controlled, stepwise hemorrhagic hypotension.." Circulatory shock, 1991.
RethinkPeptides
RethinkPeptides Research Database. "Endogenous opioid peptides and blood pressure regulation dur..." RPEP-00216. Retrieved from https://rethinkpeptides.com/research/van-1991-endogenous-opioid-peptides-and
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.